Fast-Track

Fast-Track is a specialized, privately-held contract research organization (CRO) focused on accelerating the development of drugs and biologics for its clients. The company offers end-to-end services from clinical trial design and management to regulatory strategy and funding assistance, leveraging a 'critical path planning' approach to shorten timelines to licensure. Operating as a service provider, it generates revenue from client contracts and targets a broad market of biopharma companies seeking external development expertise. Its model is inherently diversified across multiple client projects rather than reliant on a proprietary pipeline.

Integrated CRO service suite centered on a 'critical path planning' methodology for accelerating drug/biologic development, encompassing clinical trial design/management, data analysis, regulatory strategy, and funding assistance.

Fast-Track competes in the vast Contract Research Organization market, directly against other boutique strategic/regulatory CROs and indirectly against large, full-service global CROs like IQVIA, Parexel, and PPD. Its differentiation is its focused expertise on the critical path to licensure for vaccines and biologics, offering a high-touch, strategic partnership model versus the transactional, large-scale operations of bigger players.